FABP4 and Hypertension: Patients with FABP4 levels above the median (22.79 ng/ml) were more likely female (41% vs. 16%, p < 0.001) and were older (66 years vs. 60 years, p < 0.001), presented with a higher rate of hypertension (85% vs. 64%, p < 0.001) and diabetes (23% vs. 12%, p = 0.018), a higher BMI (29 kg/m2 vs. 26 kg/m2, p < 0.001), a lower eGFR (79 ml/min vs. 105 ml/min, p < 0.001), higher hs-cTnT levels (12 ng/L vs. 8 ng/L p < 0.001), higher NT-proBNP levels (180 ng/L vs. 113 ng/L, p < 0.001), and higher CRP levels (0.2 mg/dl vs. 0.1 mg/dl, p < 0.001).